AUROPHARMA — Aurobindo Pharma Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual cashflow statement for Aurobindo Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	C2019 March 31st	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Interim Report	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	30,914	37,430	73,436	33,727	26,125
Depreciation
Non-Cash Items	1,460	1,245	-27,180	2,176	3,419
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-22,543	-4,529	-23,296	2,964	-18,058
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	16,510	43,813	33,513	50,132	23,932
Capital Expenditures	-15,591	-14,311	-18,738	-27,046	-27,204
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-13,435	-1,366	24,725	-5,069	-12,574
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-29,026	-15,676	5,987	-32,116	-39,778
Financing Cash Flow Items	-1,654	-1,394	-481	-185	-1,112
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	19,191	-19,472	-13,648	-29,693	18,144
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	6,656	8,712	25,831	-11,674	2,298